Clinical Trials on Moderate and High Risk Myelofibrosis in South Africa
Total 237 results
-
Edwards LifesciencesActive, not recruiting
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Prisma Health-UpstateRecruiting
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
AbbVieTerminatedMyelofibrosis (MF)United States, Korea, Republic of, South Africa
-
Brown UniversityCompletedPrevention or Reduction of HIV Risk Behavior | Prevention or Reduction of Intimate Partner ViolenceSouth Africa
-
North-West University, South AfricaGlaxoSmithKline; Novartis; Pfizer; Boehringer Ingelheim; Medical Research Council; Medical... and other collaboratorsActive, not recruitingCardiovascular Diseases | Hypertension | Health Risk Behaviors | Arterial Stiffness | Young | Renin HypertensionSouth Africa
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Antiva BiosciencesCompletedCervical Cancer | Human Papilloma Virus | HSIL, High Grade Squamous Intraepithelial Lesions | Cervical Dysplasia | HSIL of Cervix | High-Grade Cervical Intraepithelial Neoplasia | HIV Negative | CIN - Cervical Intraepithelial Neoplasia | Cervical NeoplasmSouth Africa
-
Keros Therapeutics, Inc.IQVIA BiotechRecruitingMyelofibrosisAustralia
-
Kartos Therapeutics, Inc.RecruitingPrimary Myelofibrosis (PMF) | Post-Polycythemia Vera Myelofibrosis (Post-PV-MF) | Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)United States, Mexico, Bulgaria, Poland, Russian Federation, Belarus, Georgia, South Africa, Ukraine
-
University of PretoriaUniversity of StellenboschRecruitingCervical Cancer | CIN2 | High Grade SilSouth Africa
-
BayerCompletedModerate Risk of CVDPoland, United States, Italy, United Kingdom, Germany, Spain, Puerto Rico, Ireland
-
Merck Sharp & Dohme LLCRecruitingPrimary Myelofibrosis | Polycythemia Vera | Thrombocythemia, Essential | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisAustralia, New Zealand
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Royal North Shore HospitalRecruiting
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedMyelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)Germany, United States, Australia, Italy, United Kingdom
-
Alnylam PharmaceuticalsRecruitingHypertension | High Cardiovascular RiskUnited States, Canada
-
RTI InternationalUniversity of North Carolina, Chapel HillCompletedSexually Transmitted Diseases | HIV | Substance Abuse | Violence | Victimization | Sexual RiskUnited States, South Africa
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Belgium, Bulgaria, Canada, Croatia, France, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Serbia, Spain, Taiwan, Turkey, United Kingdom
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Spain, Sweden, Taiwan, Turkey and more
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Puerto Rico, Russian Federation, Serbia, South... and more
-
Novartis PharmaceuticalsActive, not recruitingMyelofibrosisUnited Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
University of the West of ScotlandSwansea UniversityCompletedTo Assess the Impact of the HIT Intervention on Physiological Responses | To Assess the Role of a Secondary High School as a Setting for Promoting Healthy Eating and PA Behaviours | To Determine the Associations Between CVD Risk Factors at Baseline in 15 - 18 Year Old YouthUnited Kingdom
-
Institut PasteurInstitut Pasteur de Madagascar; Action Contre la Faim; Centre de Recherches Médicales... and other collaboratorsCompletedModerate Acute MalnutritionCentral African Republic, Madagascar, Niger, Senegal
-
Geron CorporationCompletedMyelofibrosisUnited States, France, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Korea, Republic of, Canada
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedHigh Risk Acute Myeloid LeukemiaUnited States, Canada
-
Biosensors Europe SAActive, not recruitingAcute Coronary Syndrome | High Bleeding RiskUnited States, Canada, France, Italy, United Kingdom, Germany, Denmark
-
Geron CorporationRecruitingMyelofibrosisUnited States, Australia, Italy, India, United Kingdom, Israel, Taiwan, Poland, Malaysia, Argentina, Spain, Turkey, Belgium, Germany, Austria, Brazil, Bulgaria, Colombia, Denmark, France, Georgia, Hungary, Korea, Republic of, Portugal, ... and more
-
Sumitomo Pharma America, Inc.RecruitingMyelofibrosisUnited States, Japan, Australia
-
CelgeneCompletedPrimary Myelofibrosis | AnemiaUnited States, France, Italy, United Kingdom
-
Incyte CorporationCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
PfizerTerminatedModerate-severe PainUnited States
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
AbbVieCompletedMyelofibrosisArgentina, Australia, Brazil, Canada, Colombia, Greece, Italy, Mexico, Poland, Portugal, Romania, Taiwan, Turkey, United States
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
University of SheffieldCompletedLong-term Physical Health Conditions | Mild to Moderate Anxiety and/or DepressionUnited Kingdom
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
SanofiCompletedHematopoietic NeoplasmAustria, Germany, Italy, Spain, United Kingdom, France, Belgium, Israel, Sweden, Australia, United States, Lithuania, Portugal, Korea, Republic of, Singapore, Taiwan, Mexico, Brazil, Canada, Hungary, Ireland, Poland, Romania, Russian... and more
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Germany, Spain, Israel, Bulgaria, Romania, Japan, Taiwan, Korea, Republic of, Australia, Belgium, Canada, Netherlands, Singapore, Poland, Hungary, Denmark, Sweden, United Kingdom, Czechia, Austria
-
GlaxoSmithKlineActive, not recruitingNeoplasms | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)United States, Hungary, Israel, Spain, Taiwan, France, Australia, Germany, Belgium, Canada, Singapore, Korea, Republic of, United Kingdom, Denmark, Austria, Romania, Italy, Bulgaria, Poland, Netherlands
-
Prisma Health-UpstateIndiana University; Orthopaedic Trauma AssociationCompletedHigh Energy Midshaft Clavicle FracturesUnited States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)Canada, United States, Australia